ZAMBONI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 2.338
EU - Europa 1.245
AS - Asia 1.186
SA - Sud America 181
AF - Africa 22
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.977
Nazione #
US - Stati Uniti d'America 2.290
PL - Polonia 477
SG - Singapore 448
CN - Cina 317
DE - Germania 187
BR - Brasile 158
UA - Ucraina 155
VN - Vietnam 115
HK - Hong Kong 114
FI - Finlandia 87
GB - Regno Unito 68
RU - Federazione Russa 62
TR - Turchia 55
IT - Italia 54
IE - Irlanda 40
IN - India 37
CA - Canada 28
FR - Francia 28
BE - Belgio 20
ID - Indonesia 20
SE - Svezia 20
BD - Bangladesh 15
IQ - Iraq 15
ES - Italia 13
JP - Giappone 12
MX - Messico 11
AT - Austria 9
ZA - Sudafrica 8
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
IR - Iran 6
NL - Olanda 6
PK - Pakistan 5
AR - Argentina 4
AU - Australia 4
CZ - Repubblica Ceca 4
LT - Lituania 4
AZ - Azerbaigian 3
CO - Colombia 3
DZ - Algeria 3
PA - Panama 3
SA - Arabia Saudita 3
BB - Barbados 2
ET - Etiopia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
NP - Nepal 2
PT - Portogallo 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 4.977
Città #
Warsaw 477
Ashburn 321
Fairfield 269
Singapore 183
Woodbridge 124
Beijing 122
Jacksonville 122
Hong Kong 114
Seattle 110
Cambridge 99
Houston 96
Wilmington 89
Ann Arbor 83
New York 83
Princeton 75
Chandler 74
Los Angeles 63
Helsinki 62
Munich 61
Dong Ket 50
Dublin 40
Istanbul 38
The Dalles 30
Boardman 24
Ho Chi Minh City 24
Shanghai 24
Turku 23
Washington 22
Brussels 20
Des Moines 20
São Paulo 20
Hanoi 18
Moscow 18
San Francisco 17
Jakarta 16
Redondo Beach 16
Chicago 14
Dallas 14
Nanjing 14
Santa Clara 14
Buffalo 13
San Diego 13
Falkenstein 12
London 12
San Mateo 12
Atlanta 11
Kocaeli 11
Montreal 11
Augusta 10
Shenyang 10
Tokyo 10
Milan 9
Baghdad 8
Chennai 8
Council Bluffs 8
Dearborn 8
Denver 8
Düsseldorf 8
Jinan 8
Monmouth Junction 8
Nuremberg 8
Phoenix 8
Stockholm 8
Tianjin 8
Toronto 8
Johannesburg 7
Manchester 7
Mexico City 7
Nürnberg 7
Vienna 7
Ardabil 6
Boston 6
Brescia 6
Nanchang 6
Brooklyn 5
Changsha 5
Da Nang 5
Haikou 5
Hebei 5
Honolulu 5
Leawood 5
Orem 5
Porto Alegre 5
Rio de Janeiro 5
San Jose 5
Ankara 4
Bari 4
Frankfurt am Main 4
Guangzhou 4
Guayaquil 4
Jiaxing 4
Norwalk 4
Parma 4
Poplar 4
Vancouver 4
Zhengzhou 4
Baku 3
Belford Roxo 3
Brasília 3
Charlotte 3
Totale 3.511
Nome #
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 221
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 212
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 211
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 207
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 189
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 182
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 163
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 161
Prediction tools in non-muscle invasive bladder cancer 155
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 152
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 149
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 144
Histological variants in non-muscle invasive bladder cancer 141
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 125
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 124
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration 124
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 115
The effect of perioperative blood transfusion on oncological outcomes in radical cystectomy patients: a narrative review 113
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 112
Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy 110
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes 109
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis 106
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 105
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 100
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 99
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 99
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit 98
Single postoperative instillation for non-muscle invasive bladder cancer: Are there still any indication? 96
CLINICAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER, DEFINING OPTIMAL SURVEILLANCE AFTER SURGERY 94
A thigh urinary fistula following radical prostatectomy and external beam radiation therapy for prostate cancer: a case report 92
INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION 89
THE IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN IN UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS TREATED WITH NEPHROURETERECTOMY: A MULTICENTER COLLABORATION 85
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 84
COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMYIN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION 76
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 74
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 70
Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer 70
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 70
THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER 66
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 55
Precision medicine in localized bladder cancer: Personalizing therapies to improve outcomes 54
THE NECESSITY OF A SECOND TRANSURETHRAL RESECTION FOR PATIENTS DIAGNOSED WITH PTAHG TUMOR AT FIRST TUR: A MULTICENTER COLLABORATION OF EAU YOUNG ACADEMIC UROLOGISTS UROTHELIAL CARCINOMA GROUP 52
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 41
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 18
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial 18
null 13
Totale 5.043
Categoria #
all - tutte 25.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021639 0 0 0 0 0 108 64 90 83 121 91 82
2021/2022327 31 57 5 13 11 23 5 26 16 33 22 85
2022/2023264 40 5 7 19 20 62 2 28 45 0 24 12
2023/2024489 22 6 34 54 29 133 7 40 67 12 5 80
2024/2025869 10 5 3 123 76 72 84 43 122 56 160 115
2025/20261.130 186 189 109 280 245 121 0 0 0 0 0 0
Totale 5.043